Studies have indicated a mutual exclusivity between miR-34a methylation and p53 mutation in CRC, suggesting either miR-34a inactivation or p53 mutation in tissues or cells (Vogt et al., 2011). This evidence concerns the gene TP53 and colorectal carcinoma.